Erin Nicole Knapp, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 105 Sw Eagles Pkwy, Grain Valley, MO 64029 Phone: 816-265-1170 |
Sierra Renee Pollard, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 105 Sw Eagles Pkwy, Grain Valley, MO 64029 Phone: 816-265-1170 |
Monica R Carrier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 Nw Jefferson St, Grain Valley, MO 64029 Phone: 816-847-8279 |
Katherine Love, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 853 Sw Woodland Dr, Grain Valley, MO 64029 Phone: 816-590-3211 |
Ashley Howard Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 105 Sw Eagles Pkwy, Grain Valley, MO 64029 Phone: 816-265-1170 |
Kaitlin Doyle Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 105 Sw Eagles Pkwy, Grain Valley, MO 64029 Phone: 816-265-1170 |
Mrs. Karien Koen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 802 Sw Lakeview Dr, Grain Valley, MO 64029 Phone: 816-714-4723 |
Dr. Brooke Alexa Mullendore, OTR/L, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 105 Sw Eagles Pkwy, Grain Valley, MO 64029 Phone: 816-526-5117 Fax: 816-443-5692 |
Allison K Hieber Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31606 Ne Pink Hill Road, Grain Valley, MO 64029 Phone: 816-847-5006 Fax: 816-229-4831 |
Cwo Enterprises Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 105 Sw Eagles Pkwy, Grain Valley, MO 64029 Phone: 816-507-1669 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today.
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced that results from a real-life, retrospective, observational study of QVAR- will be presented at the American Thoracic Society (ATS) 2014 International Conference in San Diego on May 18, 2014.
The US FDA's advisory panel's decision to recommend against approval of Acura Pharmaceuticals/King Pharmaceuticals' Acurox (oxycodone plus niacin) was based upon the view that data were lacking that niacin-induced flushing could potentially reduce misuse of Acurox with single-ingredient oxycodone. The panel also contended that clinical studies were not conducted in populations that might be likely to benefit from the drug's purported abuse-deterrent properties, such as those with chronic pain and adolescents who are experimenting with drug use.
› Verified 7 days ago